HarborSite

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.

Immitra Bio

This company develops an in-vivo gene editing platform to provide off-the-shelf curative treatments for patients with rare genetic diseases.

Shape Therapeutics

The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.

Code Bio

This company develops non-viral genetic medicine delivery platforms and therapies for patients with rare and prevalent genetic diseases.

Arbor Biotechnologies

This company develops programmable gene-editing tools and genetic medicines to treat patients with liver and central nervous system diseases.

Chameleon Biosciences

This company develops immune-evading gene therapy delivery platforms for pharmaceutical firms and patients with genetic disorders.

Anjarium BioSciences

This company develops non-viral gene therapies and synthetic DNA vectors for patients with genetic diseases and life sciences researchers.

Stridebio

This company develops engineered viral vectors and gene therapies for patients with rare genetic diseases.